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Abstract 
Background  
The supply of naloxone, the opioid antagonist, for peer administration (‘take-home 
naloxone’ (THN)) has been promoted as a means of preventing opioid-related deaths for 
over 20 years. Despite this, little is known about PWID experiences of take-home naloxone 
administration. The aim of this study was to advance the evidence base on THN by 
producing one of the first examinations of the lived-experience of THN use among PWID.   
Methods 
Qualitative, face to face, semi-structured interviews were undertaken at a harm reduction 
service with individuals known to have used take-home naloxone in an overdose situation in 
a large urban area in Scotland. Interpretative Phenomenological Analysis (IPA) was then 
applied to the data from these in-depth accounts. 
Results 
The primary analysis involved a total of 8 PWID (seven male, one female) known to have 
used take-home naloxone. This paper focuses on the two main themes concerning naloxone 
administration: psychological impacts of peer administration and role perceptions. In the 
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former, the feelings participants encounter at different stages of their naloxone experience, 
including before, during and after use, are explored. In the latter, the concepts of role 
legitimacy, role adequacy, role responsibility and role support are considered.  
Conclusion 
This study demonstrates that responding to an overdose using take-home naloxone is 
complex, both practically and emotionally, for those involved. Although protocols exist, a 
multitude of individual, social and environmental factors shape responses in the short and 
longer terms. Despite these challenges, participants generally conveyed a strong sense of 
therapeutic commitment to using take-home naloxone in their communities. 
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Introduction 
The supply of naloxone, the opioid antagonist, for peer administration (henceforth ‘take-
home naloxone’ or THN) has been promoted as a means of preventing opioid-related deaths 
for over 20 years (Strang et al, 1996; Strang et al, 2006; Strang et al, 2014).  
In Scotland, a national naloxone programme is in place where those at risk of opioid 
overdose are typically supplied with THN via community addiction and harm reduction 
services (including community pharmacy) following successful completion of a brief 5-10 
minute training session (McAuley et al, 2012; Bird et al, 2016; McAuley et al, 2016; Bird et 
al, 2017). THN is also offered to all prisoners on release who are deemed to be at risk of 
opioid overdose. Core elements of the training individuals undertake prior to naloxone 
supply include signs and symptoms of opioid overdose, basic life support, naloxone 
administration, and calling an ambulance.  
The bulk of research on THN to date has focussed on quantitative measures that have 
examined the impact of training and supply of THN on knowledge, confidence and overdose 
responses, before and after training, and at short term follow up intervals (Clark et al, 2014; 
Mueller et al, 2015; McAuley et al, 2015). Collectively, these studies highlight that people 
who inject drugs (PWID) internationally can successfully be trained to identify and respond 
to overdose events using basic life support and naloxone administration techniques.   
Far fewer studies have been conducted that have focussed more on PWID’s views and 
experiences of administering THN and the impact this has on them. To date,  those which 
have been published mainly originate from North America (Worthington et al, 2006; 
Shermann et al 2008, 2009; Wagner et al, 2014; Lankenau et al, 2014; Koester et al, 2017; 
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Heavey, 2018), and one from China (Bartlett et al, 2011). Collectively, these studies provide 
valuable early insights into the barriers and enablers to participating in THN programmes, 
but also to the attitudes of the individuals involved and the effects naloxone can have on 
them and their relationships with their peers. Related themes of security, trust and comfort 
emerged from different studies, and how this new naloxone role within their community 
had given many a sense of dignity and purpose in their life.  
To our knowledge, only one such study has been published from the UK, which explored 
hypothetical scenarios with homeless drug users who had yet to be prescribed THN (Wright 
et al, 2006). For example, participants reported a willingness to take responsibility and 
‘save’ a fellow drug user if required to do so, but it is unclear if this motivation would have 
translated into action with naloxone at an actual opioid-related overdose event.  
Neale and Strang (2015) argue that “better understanding of opiate users’ views and 
experience of emergency naloxone is needed to support medical care and decision-making 
and to inform the wider pre-supply of naloxone”.  This is particularly relevant to the UK 
where national naloxone programmes have been pioneered. The aim of this study was to 
advance the evidence base on THN by producing one of the first examinations of the lived-
experience of THN among PWID in the UK.   
Theoretical approach  
This study adopted Interpretative Phenomenological Analysis (IPA) as its guiding 
methodological framework. In keeping with IPA principles, no theory is applied until the 
analysis is concluded (Smith et al, 2009). The roots of IPA lie in three major areas of 
philosophy: phenomenology, hermeneutics and idiography (Smith, 2004). 
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IPA owes much to Husserl’s phenomenological principles, in particular its focus on detailed 
exploration of lived experience (Smith, 2004; Wagstaff et al, 2014). The aim of IPA is to 
explore in detail an object/event of importance to an individual, in this case administration 
of THN by PWID.    
In terms of hermeneutics and theories of interpretation, IPA acknowledges the difficulties in 
accessing an individual’s perception of their personal world and outlines an empathic but 
critical interpretative process which actively involves the researcher to overcome these 
difficulties (Smith, 2004; Wagstaff et al, 2014). Access to perception is reliant on, but also 
complicated by, the researcher’s own theoretical beliefs which are necessary to understand 
the personal world being described by the participant (Smith & Osborn, 2008). This involves 
both the participant and the researcher in a two-stage interpretative process: participants 
trying to make sense of their own world; researcher trying to make sense of the participants 
trying to make sense of their own world: often referred to as the ‘double hermeneutic’ 
(Smith & Osborn, 2008).    
As well as being both phenomenological and interpretative, IPA is strongly idiographic in 
approach; each case is considered in isolation as well as in consideration of the implications 
each individual experience may have within the context of the whole sample (Smith, 1996; 
2004; Smith et al, 2009; Larkin et al, 2006; Gee, 2011). It adopts a position that the 
participant provides an active insight into their world with no assumptions about objective 
reality or truth and where a theoretical rather than scientific generalisability is produced 
(Wagstaff et al, 2014).   
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Little is known about the lived experience of THN use among people who inject drugs. IPA is 
useful in this context as it allowed the research to examine in-depth the lived experience of 
people who had used naloxone by interpreting their accounts through analysis of the 
language used to make sense of that experience. Moreover, IPA helps to relay, as best as 
possible, what it is like to “walk in another’s shoes” (Shaw, 2010: pg. 181).   
Study Methods 
 
Fieldwork was conducted between July and October 2013 within a large urban Health Board 
in Scotland, UK: an area with one of the highest prevalence rates of PWID in the country. 
IPA studies require small homogenous samples to allow participants scope to relay their 
experience in full and the researcher to fully connect with what is being described; they thus 
follow a purposive sampling path, akin to a series of case studies (Smith et al, 2009). 
Although no definitive sampling guidance for IPA studies exists, Reid and colleagues suggest 
a maximum of ten participants in an IPA study (Reid et al, 2005). We therefore aimed to 
recruit 10 individuals who had used THN to reverse an overdose into the study. Potential 
participants were invited to take part in the study when attending a busy harm reduction 
service for routine appointments. The site was chosen due to its size and because it 
provided both opiate substitution therapy (OST) and injecting equipment, therefore 
attracting a large group of individuals with differing intensities of drug use. 
The initial invitation to participate was made by a harm reduction team staff member who 
then directed those expressing an interest to an independent researcher (AMcA) where they 
were provided with a study information sheet and given the opportunity to ask questions. 
8 
 
Potential study participants were then asked to provide written consent prior to data 
collection. All individuals approached agreed to take part and consented with no exceptions.     
Face to face, semi-structured, in-depth interviews using a topic guide were conducted by 
the lead researcher (AMcA) in a private room within the service, and were audio recorded 
where consent was given to do so. The topic guide covered overdose history and risk, 
feelings about naloxone, and experience of using naloxone at an overdose event.   
Participants were assured that the interviews were anonymous and confidential and that 
pseudonyms would be used in place of real names and places in any publications or reports.  
Interviews lasted between 30 and 70 minutes and participants were given a £10 shopping 
voucher to compensate them for their time. Appropriate ethical and management approvals 
were granted from the NHS West of Scotland Research Ethics Service (WoSRES), the local 
NHS Research and Development department and the University of the West of Scotland.  
Analysis 
All interviews were digitally recorded and transcribed verbatim by the lead researcher 
(AMcA) with the exception of one who refused to consent to recording and only gave 
permission for handwritten notes to be taken. Anonymised transcriptions were entered into 
NVIVO (version 10) to facilitate analysis. Analysis was conducted by the lead researcher 
(AMcA) and reviewed by the research team (AM, AT).  Differences in interpretation were 
discussed in detail at regular research team meetings and resolved by consensus.  
The IPA analysis was conducted in four stages in accordance with Smith & Osborn (2008): (1) 
Identification of initial themes; (2) connecting themes; (3) tabling of themes; (4) analysing 
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further cases. During the initial stage, notes are taken on any points of interest or 
significance; these range from descriptive notes (e.g. objects, events), to linguistic 
comments (e.g. repetition, hesitancy, metaphor), to conceptual observations where the 
researcher begins to interpret and question the data (Smith et al, 2009). Ultimately, the 
analysis should generate an extended narrative which illustrates how the researcher thinks 
the participant is thinking (Smith et al, 2009).  It is this interpretative narrative, introducing 
and analysing experiential themes, which Smith (2011) argues is the key difference between 
IPA and other thematic-based approaches and yields an analytical account which is not 
descriptive but entirely phenomenological. 
Results  
In total, nine interviews were completed with individuals (2 female, 7 male) who had used 
naloxone to reverse an overdose, but only eight of these were included in the final analysis 
(one participant had shown signs of intoxication as the interview progressed and the data 
from that interview was not deemed ethical to use). Full details of the sample 
characteristics are available in Table 1. 
INSERT TABLE 1 HERE 
The final eight participants were white, from across all age-groups (16-54 years) and 
included one female. Half of interviewees had been opioid users for over 10 years, and half 
reported that they were still injecting drugs (all were injecting at the time of their naloxone 
administration). All bar one were currently engaged in drug treatment, typically methadone-
based OST. In addition, all had witnessed at least one overdose in the past, and five had 
overdosed themselves.   
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This paper focuses on the two main themes concerning naloxone administration: 
psychological impacts of peer administration and role perceptions.  
Psychological impacts of peer naloxone administration  
Experiences pre-naloxone use  
The first time that participants had occasion to administer naloxone, prior to its use many 
participants described a chaotic scene, repeatedly using the word “panic” to emphasise 
their sense of alarm and anxiety within the context of using naloxone for the first time. The 
participants linked these emotions to multiple drivers: a lack of preparation for what was 
encountered; the desire to respond quickly; the perilous state of the victim; and the fear of 
being blamed whatever the outcome. Others attributed their apprehension to inexperience 
with overdose, naloxone or of injecting others, contributing to an expectation that they 
wouldn’t have to ever use their kit. These stresses, alone or in combination, often 
contributed to overdose responses based on instinct rather on following protocol. For 
example, prior to using his naloxone kit for the first time (below), Dylan’s emphasis is very 
much on speed and time rather than structure and process: 
“Oh, I, I was panickin’, eh, I was in a rush, I didn’t walk through, I ran through and ran 
back, eh. You know, eh, I was, I was panickin’, eh. As I said, I’ve never seen it like that 
bad before, eh, and you know you hear all these stories you know, eh, when 
somebody’s OD’d [overdosed] and you get blamed and all of that.  And all these 
things that can happen and it goes through your head in about half a second, eh.  
And it’s like really what do we do, eh? Real panic, eh, I mean it was really scary, eh.” 
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Dylan, 25-34 years old 
Difficulties prior to administering naloxone for the first time to his close friend were also 
noted by Davie. Like Dylan he also refers to a sense of panic within himself prior to using the 
drug, but within a different context. In Davie’s example, below, his lack of confidence 
related to whether or not he would apply his training correctly. His shaking hands capturing 
his sense of panic as he steadied himself before administering the drug:  
“Em, I was quite nervous, aye [yes], my hands started shakin’ a wee bit, basically, cos 
[because] I was just gonna give him the naloxone first and I ‘hink that’s when all the 
panic started hittin’ me in the heid [head] basically with my hands shakin’ a wee bit.  
Sayin’, ‘oh, am I gonna put it in the right place here...?’” 
Davie, 35-44 years old 
Prior expectations about administering naloxone emerged from Jade and Liam’s accounts, 
two of the youngest participants in the study. When she was first supplied with naloxone, 
Jade did not think she’d have to ever use it as she and her partner had never overdosed 
before. Liam also had an initial expectation that he would never have cause to use his 
naloxone kit, based on his lack of direct experience of overdose within his drug using 
network. This is highlighted in the extract below, with the emphasis on “really” in the final 
sentence perhaps a sign that Liam’s is recalling his successful use of naloxone during his 
response:  
“At first I thought, like…I was happy to take it [naloxone] straight away but I thought 
ken [you know], well in a way I was like, ‘what’s the point, I’m not going to need it.  
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Everybody that I’m with has never like overdosed or anything like that’.  So I was like, 
‘there’s not really any point’.  But I was happy to take it and I’m glad I did. [Right] I’m 
really, really, really glad I did.” 
Liam, 16-24 years old 
Experiences post-naloxone use  
Many participants contrasted their pre-naloxone administration feelings of alarm and 
anxiety with a post-administration sense of relief and pride; primarily at seeing the naloxone 
work and their own role as a lifesaver. Below, the quote from Jack shows how he quickly 
moved from the fear related to the initial physical response to elation associated with a 
successful outcome. It appears that his adoption of the role of lifesaver is what made Jack 
feel so good about his intervention. However, it is notable that Jack described using 
naloxone to save his drug dealer which may also have influenced his emotions if he was 
dependent on him for his drug supply. When prompted to compare it to his previous 
overdose intervention attempts, Jack pointed to the naloxone itself as a key component in 
his new found empowerment:  
“R Oh, it felt great. Bringing somebody back to life, ken.  It felt, it was scary but it 
felt good that I’d brought him back to life.  Ken what I’m saying? 
I Right.  And did it feel, would, was that experience any difference to the ones 
in the past that you’d dealt with? 
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R I think the ones before were scarier because I never had that [naloxone] or 
anything.  Ken what I’m saying?  I just had to put them in the recovery 
position and hope for the best for them, ken what I’m saying?” 
Jack, 35-44 years old 
Davie also took positives from his naloxone experience, the juxtaposition of Davie’s his 
shaking hand slowing down as his friends heart came back up to speed capturing the 
moment that he knew everything was going to be ok. Notably, Davie referred to the 
uniqueness of the feelings he experienced:  
“But as soon as I said, as soon as he started to come around and that and I 
thought…and my hand started slowing down a wee bit more, I was quite relieved, 
quite proud to [] I’ve never felt like that before as I say, as I say that was my first, my 
first mate I’ve ever saved, ken, and hopefully my last, touch wood [laughs].” 
Davie, 35-44 years old 
Others relayed mixed feelings after administering the naloxone. In Walter’s example 
(below), he is glad that it worked, but he also expressed disappointment that it never 
brought his peer completely round. This is particularly poignant for Walter as he was 
describing administering naloxone to his brother. He expected to see an immediate effect 
after administering the naloxone, but upon realising that wasn’t the case he felt 
disappointed. Ultimately, Walter wanted to be a lifesaver, but he felt as if his intervention 
had not justified that title which he never assumes in the extract below:  
“I And how did it feel to see it [naloxone] actually working? 
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R I was just kinda glad.  It says, like it says you can be a lifesaver.  And I was like, 
I thought it was, just reversed the opiate straight away.  But obviously it 
doesn’t, you can still die after it.  But I didn’t know that.  I thought you could 
be alright.  But he was still going under so I didn’t feel that good cos it never 
worked that...that well.” 
Walter, 45-54 years old 
Negative peer reactions to naloxone administration 
Some participants described negative reactions to their naloxone administration from those 
they were attempting to help, including both verbal and physical abuse. As well as the onset 
of acute withdrawal, the reasons for these negative responses from peers were wide 
ranging and included: resentment of being robbed of their “hit”; umbrage at interruption of 
a suicide attempt; perception of drug theft; and lack of awareness of fatal overdose risk.  
Negative reactions from the overdose victims often sparked parallel resentment from those 
administering naloxone who felt undermined in their attempts to save someone’s life. For 
example, Andy, who had used naloxone many times, relayed his own resentment about 
someone he saved, the aggression in his language emphasising how aggrieved he was at this 
reaction:  
“…The guy didn’t say thanks, you know. And, eh, there was no thanks.  He was like, 
‘great, now my stone’s away, I’m bloody rattling’, and all this. I was like…you know, 
kinda pissed me off a bit.  I’ll be honest, I did say, ‘I should have fucking left you 
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alone!’, you know? But I didn’t mean it when I said it. I meant it but I didn’t actually 
really mean it, you know what I mean?” 
Andy, 45-54 years old 
Other participants described relationship breakdowns after administering naloxone to 
friends.  For example, Liam was upset that his best friend, with whom he shared a home, 
had used heroin immediately after he revived him with naloxone. Indeed Liam threatened 
to move out of the house they shared if he did so, a threat he ultimately carried out. Liam’s 
anger appears to be principally drawn from his ultimatum, which his friend, his housemate, 
ignored: 
“I was not happy.  I’d been, I told him, well in all honesty I told him if he was to go 
and buy another bag [of heroin] I’d move out.  And he went away and bought 
another bag.  And I ended up moving out.  And now I’m in a bed and breakfast. I 
really, really was not happy with him doing it [using more heroin].” 
Liam, 16-24 years old 
Simon had used naloxone on a “drug friend” who now no longer spoke to him because of his 
intervention. Unlike Liam, he relayed no emotional attachment to the individual he saved, 
yet like the other participants he still felt compelled to intervene indicating his willingness to 
help despite the context of the overdose situation. Notably, Simon showed no resentment 
or sense of feeling undermined by the victim’s reaction, contrasting the reactions of others:  
“I Has your relationship with him changed since you’ve given the naloxone? 
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R Aye, he doesn’t speak to me now. 
I Right, does it bother you or…? 
R Well at the end of the day he was just a drug friend eh.” 
Simon, 16-24 years 
Positive peer reactions to naloxone administration 
In contrast to negative reactions, there were also participants who described how their 
naloxone experiences had strengthened relationships between peers. For example, Davie 
recalled how his bond with his close friend he had saved was now stronger than before. The 
gratitude shown here is markedly different to some of the negative feedback experienced 
by others and possibly a reflection of the strength of the relationship which existed between 
Davie and his friend:  
“...I mean he ended up comin’ back and apologised, he’s sayin’ ‘look I’m sorry I, the 
way I reacted as obviously I knew, realised that if you hadn’t done that I wouldn’t 
have been here basically to thank you’.  And I was like ‘well obviously I would like to 
think you would have done the same for me’, kinda thing.  He was like ‘aye’ he, he 
kinda stood by it and agreed with me on certain things basically, I ‘hink he was quite 
happy basically as I say he’s now back with his Mrs and that and his children.” 
Davie, 35-44 years old 
Behaviour change since using naloxone  
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Behaviour changes associated with naloxone experiences were evident for some 
participants. These included changes in day-to-day drug taking behaviour, responses to 
overdose, and examples of psychological changes that were attributed to experiences with 
THN.   
For example, since using naloxone Liam described changes in both his social norms of drug 
consumption and the role of peers within such norms. The experience of saving his friend 
appeared to have also led to him to a point of contemplation where he reflected on his own 
vulnerability; using comparison with Gary (the friend he saved with naloxone) to emphasise 
his inexperience and level of risk. He reinforced commitment to this new position by his 
repetition of “I willnae” [I will not]; an indication perhaps of his commitment to his new 
normal: 
“It’s [naloxone] made me, it’s made me think more about how much I’m actually 
taking in the one go. Cos like normally, sometimes I like, I just put like two or three 
[heroin bags], ken like in the pot at the one go.  See now, like I willnae [will not] put 
any more than one. Cos it’s made me think, ken, like if Gary’s been, if Gary’s been 
pinning [injecting] for the last thirteen years and he can go over on pinning, putting 
two bags in the pot.  If I’ve been putting two, three, ken, in the pot in the one go and 
I’ve only been injecting since the start of the year.  How quickly can I go over? [clicks 
fingers].  So that’s why I willnae put any more than one in the pot.  And I willnae, 
that’s just never gonna happen.  I willnae put any more than one in the pot, no 
matter what.  I couldn’t care if I was with five people and they were like, ‘what we’ll 
do is we’ll put the five in the pot’” 
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Liam, 16-24 years old 
Walter described how naloxone had become a much bigger priority for him since using it on 
his brother as it had given him a sense of security. It is also interesting that he, like others, 
referred to giving the whole naloxone dose. He does so to emphasise the fact that he does 
not want to leave anything to chance, regardless of the physical impact on the victim: 
“Yeah I think it’s [naloxone] pretty useful to have around.  In fact I don’t like being, 
not having it around.  But, I didn’t know you were only supposed to give the little bit.  
But I’ll continue to give the whole lot [laughs], do you know what I mean?  Cos I want 
them around completely.  I’m not wanting to put half in and then the guy, poor guy 
stops breathing again.  And it’s like put another wee bit in.  No, by the time you’ve 
finished giving him the whole lot, five injections, the poor guy’s deid [dead].  Ken 
what I mean?  So I still inject the whole lot into him.” 
Walter, 45-54 years old 
Symbolically, in the extract below Liam described naloxone in ownership terms. It had 
changed from previously being something that he had, like a useful extra, to now being 
something he needs:  
“Ken like it would, it would come in handy and it’s something that I’d need.  And now 
that I’ve had to use it, ken, I ken that’s something that I want to, ken, carry it about 
with me.  Whether it’s for a smoker or whether it’s for somebody that injects it, I’m 
gonna have it constantly.” 
Liam, 16-24 years old 
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Role perceptions: legitimacy, adequacy and responsibility 
Role legitimacy 
A key issue that emerged from the participant accounts in this study was a tension between 
perceptions of personal legitimacy and peer legitimacy in being an overdose responder 
using THN. So, while all the participants saw themselves as legitimate overdose responders, 
sometimes their peers agreed with this and sometimes they did not.  For example, Liam’s 
peers did not see the role of naloxone rescuer as relevant to him due to the fact that he was 
an inexperienced/infrequent injector and that his own risk of overdose was low. Therefore, 
it seems that, as a younger member of his peer group Liam lacked credibility, emphasised in 
his perception of being viewed as “daft”.  
“They thought I was, ken at first they thought I was daft.  They were like, cos they 
were like, ‘you’ve only just started injecting, ken, at the start o’ the year.  You’ve 
done, ken you’ve pinned like a couple o’ bags at one go, you’ve never went over’.  
He’s like, ‘so, ken, I dinnae [don’t] see the point in doing that [naloxone] cos you’re 
never gonna go over’.” 
Liam, 16-24 years old 
In contrast, Dylan hinted at the legitimacy of his role when describing how he now feels he 
is a credible source of help for his peers. In describing how his peers are “no longer scared 
to ask you for help” there is suggestion of either a culture where peers are scared to ask 
other peers for help, or that credible help at an overdose event is now available from peers 
[via THN] where it perhaps wasn’t before: 
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“...eh, I suppose it’s good, eh, you know that folk [people] can, are not scared to ask 
you for help or that, or at least know there’s help there.” 
Dylan, 25-34 years old 
Role adequacy  
Assessment of one’s own role adequacy in relation to THN varied between participants; 
from those supremely confident in their abilities, to those less assured at the outset but 
who gained confidence after using it for the first time.  
In Walter’s case, role adequacy is derived from him being an experienced injector and his 
perception that THN is just another drug to be injected. While Andy’s account (below) 
suggests that his positive experiences with naloxone have psychologically moved him from 
being incapable to capable of successful overdose response. Indeed, Andy described 
naloxone administration in the context of writing his name to emphasise its simplicity and 
how it had become easier over time: 
“I took it as, eh, I didn’t need to worry about it.  Like, ‘am I gonna fuck this up o’ the 
time?’  Once I’d done it once it was like writing your name, you know. It was 
something you know you’re capable of and you’re no gonna be worried about it.” 
Andy, 45-54 years old 
A number of participants specifically described themselves as “lifesavers” following 
successful use of naloxone and spoke of how empowering an experience this was for them. 
This identity was often derived from praise for their naloxone intervention from both peers 
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and, in particular, professionals. In the example, below, the ambulance personnel attending 
the overdose being described tell Andy on more than one occasion that he saved the 
recipient’s life which invoked pride in him and perhaps indicated that such praise means 
more to Andy coming from a professional than it does from anyone else: 
“When they came they were like, ‘you’ve saved that guy’s life like’...If it wasn’t for 
you, you really did, saved his life, well done’.  Ken that, I got the big heid after that, 
you know?  You know what I mean?  There’s him telling me I could do his job, you 
know that type thing.” 
Andy, 45-54 years old 
The impact of professional feedback on perceived role adequacy is further alluded to in 
Liam’s account. Indeed the appropriateness of Liam’s actions are reinforced firstly by the 
ambulance personnel attending and confirming he had “done perfect” and “everything 
right” and then subsequently by the nurses at his drug treatment service (e.g. “done the 
right thing”). This accumulation of praise appeared to have effectively endorsed his role 
adequacy and proved to Liam that he was also now capable [like Andy] to intervene at 
future overdose events:  
“R Aye they [paramedics] said I had done perfect.  I done everything right.  And 
they said, ken, if I’d have put him in the recovery position, that’s the only 
thing that could, ken like I could have done any better was the recovery 
position.  But I just lay him flat on his back and just put his heid right back so, 
ken, he could actually breathe and move his tongue and that was it. 
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I Right.  And how did you feel when the ambulance gave you that feedback? 
R Quite chuffed, aye I was quite chuffed that, ken, I’d done something right.  
And ken like it’s, I’ve actually done something that’s helped somebody that’s 
saved his life.  I felt, ken, really good about myself cause sometimes lately I’ve 
been feeling pretty shit.  And then with doing that and them giving me the 
feedback, ken saying that I’ve done the right thing.  And then the lassies 
[ladies] in here are telling me, ken you’ve done the right thing and that, it’s, 
it’s made me feel quite good.  And now I’m, ken I’m confident enough to see, 
like if I was to see anybody overdosing, I’m quite confident enough to go and 
help them like that [clicks fingers].  Without a shadow of a doubt I’d be able 
to do everything.” 
Liam, 16-24 years old 
Role responsibility  
Some of the participants described in detail how they now felt obligated to intervene in 
future overdoses; access to naloxone for them had effectively increased their sense of 
responsibility toward their peers. Effective use of naloxone had invoked a realisation that 
they have the ability to save others where they previously might not have been able to.  
For example, Dylan used the term “standard procedure” to highlight how he felt naloxone 
was normalised within his own routine and how it should be prioritised by everyone else. In 
his view everyone should take responsibility for overdose prevention through naloxone:  
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“Well I’m not going to plan takin’ any more drugs but a keep one [naloxone kit] in my 
house, eh, it’s standard procedure. Yeah it will always be there now, eh, just for the 
simple fact the, the area that a live in it’s quite bad for drugs, eh.  You know a 
dinnae ken why it’s not a standard procedure in everybody’s kit nowadays, eh, a 
just don’t see any reason why it shouldn’t be, eh.” 
Dylan, 25-34 years old 
Discussion  
This study provides a detailed portrait of the lived experience of THN use among PWID 
based on in-depth accounts from eight individuals in Scotland with direct experience of THN 
administration. This was achieved by applying IPA to the study of THN for the first time and 
can therefore be viewed as complementary to the existing evidence on THN.  
When administering naloxone for the first time, many of the participants in this study 
described a scene of panic where actions were based on instinct rather than any formal 
application of their training. Rome et al (2008) also found panic to be the most frequent 
emotional response described by witnesses at an overdose event. A range of individual-level 
factors were attributed to fuelling the personal stress experienced by those prior to 
naloxone administration and included lack of experience with both naloxone and overdose 
intervention, lack of preparation and the need to respond rapidly, and lack of confidence in 
themselves (i.e. self-efficacy) and in naloxone (i.e. drug efficacy). Worthington and 
colleagues (2006) reported similar issues related to overdose response where, for some of 
their participants, naloxone availability had actually increased their related stress at 
overdose incidents, not alleviated it, particularly when the participants were intoxicated 
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themselves. It is difficult to actualise the sense of panic individuals experience at an 
overdose event, but it is possible during training to provide them with coping strategies 
should such a situation occur.  
In this study, one of the reported consequences of the panic experienced in the lead up to 
using naloxone for the first time was a tendency to administer the whole dose at once and 
not smaller titrated amounts as recommended within UK national prescribing guidelines 
(British National Formulary, 2017). Lower doses of naloxone are advised because they are 
less likely to trigger acute opiate withdrawal which can be physically unpleasant for the 
patient and potentially distressing for those administering the drug. Many participants 
referred either directly or indirectly to administering the whole naloxone dose at once 
which sparked a range of negative reactions from the recipient including acute withdrawal 
and aggressiveness. The potential for naloxone administration precipitating acute 
withdrawal has been noted in other studies (Neale and Strang, 2015; Worthington et al, 
2006; Wright et al, 2006) and has been cited as a possible barrier to PWID using naloxone 
for peer administration (Sondhi et al, 2016; Sporer and Kral, 2007; Worthington et al, 2006; 
Wright et al, 2006). Although few participants in this study reported personal experiences of 
acute opiate withdrawal, their experiences of witnessing it in others to whom they had 
given naloxone were often distressing. However, such trauma was not a sufficient barrier to 
them using naloxone at future overdoses they might encounter, which the majority of them 
directly confirmed they would do if required.  
Not all reports of THN use in the literature refer to administration of the whole dose, 
however. In Norway, the majority of participants evaluated in their naloxone programme 
reported administering a titrated dosage (Madah-Amiri et al, 2017). Lankenau and 
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colleagues (2013) also found evidence of individuals in Los Angeles (USA) “calibrating” the 
amount of naloxone to administer to avoid inducing withdrawal symptoms. Importantly, 
though, it was the individuals who had more experience of administering naloxone that 
reported calibrating their dose whilst in this study most participants were describing their 
experiences of using naloxone for the first time. This suggests that naloxone administration 
technique, for some, can improve with experience. The only comparable evidence which has 
emerged from the UK, to date, is a case report of an individual in recovery who 
administered titrated doses of naloxone to a fellow hostel resident who he knew to be 
overdosing (Winston et al, 2015). Naloxone trainers should be mindful of this evidence and 
heighten focus on dose titration and its potentially negative effects to give peers the best 
chance to administer naloxone as efficiently as possible. This message should be continually 
reinforced post-training within treatment services or needle/syringe exchange services in 
the same way that other harm reduction advice is provided routinely.  
Many participants in this study described how their emotions changed during their naloxone 
administration experience; from initial feelings of alarm and anxiety at encountering the 
overdose event itself, to eventual feelings of relief and pride. Sherman et al (2008) 
discovered that any apprehensions in using naloxone for the first time were overcome on 
seeing the rapid, positive effect of the drug on the overdose victim that provided those 
administering the drug with a sense of comfort. Studies by Wagner and colleagues (2014) 
and Banjo et al (2014) also found that participants reported a sense of heroism and pride in 
their ability to save lives through naloxone. Positive experiences like these are important 
tools for those advocating for naloxone and should be at the heart of communications 
aimed at promoting greater adoption.  
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Although there were accounts of victims recovering quickly, not everyone in our study 
reported feelings of such rapid relief owing to the fact that their victims did not visibly 
respond rapidly to the naloxone. Only after a period of time had elapsed were they able to 
recognise the benefits of their actions. Participants in the study by Wagner et al (2014) 
reported experiencing similar outcome-related stress after naloxone administration due to 
the unpredictability of overdose and uncertainty whether their intervention was going to 
work. Again, training could be used as a mechanism to highlight the range of reactions 
individuals might experience and ways to deal with such situations should they arise.  
The broad range of negative reactions by recipients toward naloxone administration were 
not unexpected given what has been reported elsewhere (Wright et al, 2006; Worthington 
et al, 2006; Wagner et al 2014; Neale and Strang 2015; Heavey et al, 2018). However, the 
parallel resentment relayed by the peers administering the naloxone detailed in this study 
was unexpected and an area which has received little attention in the literature to date. We 
identified only one prior study of individuals who have used naloxone reporting feelings of 
anger and disappointment toward the recipients following administration (Wagner et al, 
2014). Future studies should consider the possibility of this and any other unintended 
consequences associated with participating in naloxone initiatives and the implications for 
training / support services e.g. debriefing and re-supply post-administration.  
These collective negative experiences also illustrate the impact that naloxone can have on 
relationships. For close [“real”] friends, trust can be at stake, while for others [“drug 
friends”] more immediate issues may be at stake such as unintentionally foiling a suicide 
attempt. One might conclude that an unintended consequence such as relationship damage 
might present a threat to individuals maintaining this commitment and adopting naloxone 
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in the long-term. Yet, despite this and other negative experiences, none of the participants 
in this study indicated a lack of willingness to do so. Indeed, some of them actually relayed 
increased determination and commitment to use naloxone to save their peers, evidence 
that the experience of saving someone’s life in this way is an empowering one. A shift in 
drug policy, from the current punitive approach adopted in the UK to one more rooted in 
harm reduction, could potentially influence the dynamic of drug use relationships moving 
forward which are often “fleeting...founded in expedience” (McLean, 2016: pg. 23).  
Positive peer reactions were less common and largely influenced by how the overdose 
victim reacted to the intervention, either in the short or longer term. In situations where 
peers were able to recognise the magnitude of what their friend had done for them (i.e. 
saved their life), relationships became much stronger over time.  
Observational studies have associated participation in THN programmes with different 
aspects of unanticipated behaviour change including reduced drug taking following its use 
(McDonald and Strang, 2016). In contrast, Heavey et al (2018) reported on a sub-sample 
using more heroin to achieve a greater high in the knowledge they had naloxone available 
as a safety net. We found no such increases in day-to-day drug taking behaviour, the few 
examples that were relayed to us described reduced or less risky drug use (e.g. injecting 
less, smoking more). In addition, participants in our study highlighted psychological shifts 
that they attributed to their experiences with THN including a willingness to use it on 
anyone regardless of previous relationships or current injecting status.  This latter point is 
particularly important in terms of the normalisation of naloxone in communities populated 
by a broad spectrum of PWID, from those actively injecting to those in recovery, and who 
may or may not interact with each other.  
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Others reflected upon how much of a priority naloxone had become for them since using it 
at an overdose event, a theme which also emerged in the study by Heavey and colleagues 
(2018). In essence, it appears that each participant shifted psychologically from a pre-
naloxone position where overdose was not readily discussed or acknowledged, to a post-
naloxone recognition of their own and their peers’ vulnerability in relation to overdose. At 
the time this study was undertaken, THN was a relatively new concept within communities 
with the participants in this study forming part of a larger cohort of ‘early adopters’ 
(Rodgers, 2003). Future studies should explore to extent to which naloxone and overdose 
awareness changes as the intervention reaches a critical mass which the latest epidemiology 
suggests it has now done in Scotland (Bird et al, 2017).  
According to Shaw et al (1978), Role Adequacy relates to the degree to which practitioners 
view themselves as having the required knowledge and skills to be able to do their job 
effectively (i.e. ‘can I do this?’). Feedback from those involved in other THN programmes has 
also reported that naloxone was “easy” to administer or that PWID felt “comfortable” when 
using it (Lankenau et al, 2013; Banjo et al, 2014) often without the need for additional 
medical support (Koester et al, 2017). In this study, role adequacy varied between 
individuals and insecurities were evident owing to lack of experience, preparation, and 
confidence in themselves and in naloxone itself.  However, findings from this study suggest 
that competency in using naloxone can be bolstered via experience and validation from 
others. Perhaps the most telling sign of participants’ recognition of their own capabilities in 
relation to THN is their reference to themselves as lifesavers which epitomised the level of 
adequacy participants believed they had reached and mirrors the heroic terminology used 
by naloxone users in Los Angeles, California (Wagner et al, 2014). 
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Further reference to themselves as “lifesavers”, often after validation of their actions from 
health professionals, is an identity adopted by peers who have administered naloxone 
across different countries (Banjo et al, 2014; Shorter & Bingham, 2016; Dwyer et al, 2016; 
Heavey et al, 2018). Indeed, service providers in the study by Dwyer et al (2016) discussed 
the supply of THN as an acknowledgment by professionals that PWID can provide “expert” 
intervention which, in turn, can enhance confidence and self-esteem. Showcasing these 
examples of lifesaving and the sophistication involved in successfully administering 
naloxone at an overdose event (Faulkner-Gurstein, 2017) can contribute to fighting the 
stigma attached to drug use and people who use drugs (Lloyd, 2013) and public perception 
of harm reduction strategies more broadly.  
Role Legitimacy is used by Shaw et al (1978) to describe the extent to which practitioners 
view particular features of their work as being their responsibility (‘should I do this?’). A key 
issue that emerged in this study was a tension between personal and peer legitimacy 
related to personal factors concerning the responders (e.g. inexperience) and personal 
factors attached to the potential overdose victim (e.g. suicidal ideation). The impact of 
credibility of naloxone responders amongst their group has received little attention in the 
literature to date and merits further investigation.  
Shaw and colleagues (1978) use Role Support to categorise the assistance which 
practitioners recognise receiving from others to help them to perform their role successfully 
(‘how can I do this?’). Participants mainly described administering their naloxone in isolation 
i.e. there were no other peers or significant others nearby who could offer immediate 
support to them. This largely reflects the social and environmental landscape within in the 
UK and many other countries where drug use is criminalised and therefore hidden. Support 
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was available, though, from the attending members of the emergency services and/or their 
key-workers. Indeed, as well as bolstering role adequacy, validation of their actions by 
others in the post-naloxone period was a key factor cited by many participants in boosting 
their personal sense of relief and pride in their actions. Other studies have reported this 
same phenomenon whereby validation of actions undertaken by PWID using naloxone has 
been received from service staff (e.g. Banjo et al, 2014; Clark et al, 2014; Deonarine et al, 
2016) and peers (Wagner et al, 2014). These approvals were a source of honour for the 
individuals involved, reinforcing and strengthening their role as helpers in their 
communities. Policies such as the ‘Good Samaritan Law’ in the USA have been created to 
encourage PWID to call the emergency services without fear of prosecution, yet many still 
have underlying fear and mistrust of emergency service personnel owing to negative 
experiences which prevents them from doing so (Koester et al, 2017). Examples of positive 
interactions like those we found should be shared with emergency service personnel and/or 
key-workers at all levels, particularly within training curriculums to promote positive 
attitudes toward THN and peers who use it.  
As well as the categories offered by Shaw et al (1978), we considered another [Role 
Responsibility] which explores the extent to which participants felt compelled to intervene 
in overdose events now that they had access to naloxone (i.e. ‘I have to do this’). Prior to its 
availability as an overdose prevention tool, drug users typically relayed a potential 
willingness to use naloxone to save the life of their peers if required (Lagu et al, 2006; Strang 
et al, 1999). In this study, the actions of participants at the overdoses they encountered 
suggest that, for them, this willingness is genuine and likely to continue in future. Little is 
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known, however, about situations where naloxone is not used but available. Future research 
should explore such events and the factors associated with inaction.  
This study has some limitations which we acknowledge. First, owing to the approach to 
participant recruitment [i.e. using gatekeepers] there is a danger of recruitment bias. 
However, given that participants described such diverse experiences in terms of use of THN, 
we are confident that we have captured a range of experiences.  The potential of recall bias 
also exists in this study, as individuals were asked to recall stories retrospectively. However, 
given the relative infancy of THN an intervention when this study took place (it had only 
been implemented within the previous year), the significance of the event (the majority 
were describing their first and only naloxone administration experience to date), and the 
time and scope afforded by IPA to allow in-depth exploration of the phenomenon in 
question, it is likely that recall bias did not adversely affect the accounts relayed by 
participants. The limited female representation in our study sample is also a limitation and 
one which we hope to rectify in future work.   
Additionally, the risk of misrepresentation of participant experiences and sense making 
must be acknowledged. This risk is arguably more acute in IPA studies due to the absence of 
member-checks [where participants are offered the opportunity to review and comment on 
the interview data and analysis to determine its validity] and the potential of over-
interpretation which may be disempowering for participants. Quotations are used 
extensively throughout to mitigate this risk and illustrate the double hermeneutic concept 
which underpins IPA.  
Implications for policy and practice 
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Primarily, the findings of this study have important implications for overdose prevention 
policy and practice in Scotland and the UK by providing the first detailed insights of how 
PWID experience this key public health policy. Such in-depth exploration is important to 
inform policy makers’ future decision making about the adoption of THN programmes in 
nations where none yet exist as well as in nations where national programmes do exist, but 
may require future modification in order to achieve the best results in terms of overdose 
prevention. It is important to acknowledge, though, that THN internationally operates in 
different ways across different settings whether in relation to cost or legality and each 
“present specific affordances and impediments” (Farrugia et al, 2017: pg. 169).   
In Scotland, there is considerable evidence that the national naloxone programme is 
increasing in reach and saving lives (Bird et al, 2016; Bird et al, 2017; McAuley et al, 2016). 
Evidence from this study highlights the complexities behind these ‘saves’ for the individuals 
involved and these real life accounts can be used to inform developments in national 
training protocols. In particular, consideration must be given as to whether a brief 5-10 
minute training session is sufficient to prepare the individuals for the significant events 
peers face before, during and after naloxone administration.   
In response to a recommendation by participants in this study, stories of successful saves 
described in this research could also be used to inform policymakers and practitioners when 
developing materials to communicate THN to a wider audience. This includes those at risk of 
opioid overdose, their family/friends, health professionals and the general public. Such 
communications are vital in normalising naloxone in communities and reducing stigma, 
while at the same time positioning PWID as responsible and important community public 
health resources (Faulkner-Gurstein, 2017). 
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Conclusion  
Despite increasing adoption internationally, little is known about individuals’ day-to-day 
experiences with THN; how it is managed, communicated, and used. As one of the first 
experiential studies of individuals who have used THN, this study highlights the complexity 
of peer overdose responses using naloxone, both practically and emotionally.  
Before administering naloxone, individuals are faced with an initial difficulty of knowing 
when to intervene and the unknown intentions of the victim, in addition to the added 
responsibility of knowing that their intervention may make the difference between 
someone surviving or not. This research has illuminated an added complexity of victim 
reaction, which isn’t always warm and can have detrimental and lasting impacts on 
relationships. The pre-existing nature of these relationships is undoubtedly influential, but 
the pattern is not linear and close connections can be broken or bolstered in the aftermath 
of peer naloxone administration.   
Although protocols exist, a multitude of personal (e.g. overdose experience, naloxone 
confidence), social (relationships, network credibility, stigma) and environmental (drug 
policy) factors shape individual responses in the short and longer terms. It is important to 
acknowledge such diversity within THN training programmes and to develop ways to help 
those administering naloxone to prepare for the different outcomes that can occur. 
Additional experiential studies of this nature in different territories and across different 
opioid user groups (including prescription and illicit) are essential to our understanding of 
this life-saving intervention moving forward.   
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THN is not a panacea for opioid overdose. It is a last resort for those on the brink. The opioid 
overdose epidemics of recent times require wider individual, social and environmental 
change if they are to be reversed. This “risk environment” (Rhodes, 2009) is ultimately what 
shapes overdose risk and response and only through evidence-based application of harm 
reduction, drug treatment and policy can it be positively influenced.  
Acknowledgements 
We thank the participants in who gave up their time to contribute to this study and the staff 
at the harm reduction service who hosted the fieldwork.  
35 
 
References 
 
Bachhuber, M.A., McGinty, E.E., Kennedy-Hendricks, A., Niederdeppe, J., & Barry, C.L. 
(2015). Messaging to Increase Public Support for Naloxone Distribution Policies in the 
United States: Results from a Randomized Survey Experiment. PLoS ONE, Vol. 10(7),  
e0130050.  
Banjo, O., Tzemis, D., Al-Qutub, D., Amlani, A., Kesselring, S., & Buxton, J.A. (2014). A 
quantitative and qualitative evaluation of the British Columbia Take Home Naloxone 
program. CMAJ Open, Vol. 22; 2(3), E153-61. 
Banta-Green, C.J., Beletsky, L., Schoeppe, J.A., Coffin, P.O., & Kuszler, P.C. (2013). Police 
Officers’ and Paramedics’ Experiences with Overdose and Their Knowledge and Opinions of 
Washington State’s Drug Overdose–Naloxone–Good Samaritan Law.  J Urban Health, Vol. 
90(6), 1102-11.  
Bartlett, N., Xin, D., Zhang, H., & Huang, B. (2011). A qualitative evaluation of a peer-
implemented overdose response pilot project in Gejiu, China. International Journal of Drug 
Policy, Vol. 22, 301– 305.  
Bird, S., McAuley, A., Perry, S., & Hunter, S. (2016). Effectiveness of Scotland’s National 
Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after 
(2011-13) comparison. Addiction, Vol. 111, 883–891. 
Bird, S., McAuley, A., Munro, A., Hutchinson, S.J., & Taylor, A. (2017). Prison-based 
prescriptions aid Scotland's National Naloxone Programme. The Lancet, Vol. 389(10073), 
1005 – 1006. 
36 
 
British National Formulary. Naloxone Hydrochloride, Indications and dose, Overdosage with 
opioids in a non-medical setting. Retrieved 23 January 2018 from: 
https://bnf.nice.org.uk/drug/naloxone-hydrochloride.html  
Clark, A.K., Wilder, C.M., & Winstanley, E.L. (2014). A systematic review of community 
opioid overdose prevention and naloxone distribution programs. Journal of Addiction 
Medicine, Vol. 8(3), 153–163. 
Deonarine, A., Amlani, A., Ambrose, G., & Buxton, J.A. (2016). Qualitative assessment of 
take-home naloxone program participant and law enforcement interactions in British 
Columbia. Harm Reduction Journal, Vol. 13:17 DOI 10.1186/s12954-016-0106-1.  
Dwyer, R., Fraser, S., &Dietze P. (2016). Benefits and barriers to expanding the availability of 
take-home naloxone in Australia: A qualitative interview study with service providers. Drugs: 
Education, Prevention and Policy, doi:10.3109/09687637.2016.1150964  
Farrugia, A., Fraser, S., & Dwyer, R. (2017). Assembling the Social and Political Dimensions of 
Take-Home Naloxone. Contemporary Drug Problems, Vol. 44(3), 163-175. 
Faulkner-Gurstein, R. (2017). The social logic of naloxone: Peer administration, harm 
reduction, and the transformation of social policy. Soc Sci Med., 180, 20-27. 
Gaston, R.L., Best, D., Manning, V., & Day, E. (2009). Can we prevent drug related deaths by 
training opioid users to recognize and manage overdose? Harm Reduct. J., Vol. 6, 1–8. 
37 
 
Gee, P.M. (2011). ‘Approach and Sensibility’: a personal reflection on analysis and writing 
using Interpretative Phenomenological Analysis. Qualitative Methods in Psychology Bulletin, 
Vol. 11, 8-22. 
Green, T., & Doe-Simkins, M. (2016). Opioid overdose and naloxone: The antidote to an 
epidemic? Drug Alcohol Depend., doi: 10.1016/j.drugalcdep.2016.03.024  
Hay. G, Gannon, M., Casey, J., & McKeganey, N. Estimating the National and Local 
Prevalence of Problem Drug Misuse in Scotland. Retrieved 18 October, 2012 from: 
http://www.scotpho.org.uk/downloads/drugs/Prevalence_Report_%202006.pdf   
Heavey, S.C., Chang, Y-P., Vest, B.M. Collins, R.L., Wieczoreke, W., Homishd, G.G. (2018). ‘I 
have it just in case’ — Naloxone access and changes in opioid use behaviours. International 
Journal of Drug Policy, Vol. 51, 27–35.  
Information Services Division. Estimating the National and Local Prevalence of Problem Drug 
Use in Scotland 2012/13.  Retrieved 4 March, 2016 from: 
https://www.isdscotland.org/Health-Topics/Drugs-and-Alcohol-Misuse/Publications/2014-
10-28/2014-10-28-Drug-Prevalence-Report.pdf?14907473326    
Koester, S., Mueller, S.R., Raville, L., Langegger, S., Binswanger, I.A. (2017). Why are some 
people who have received overdose education and naloxone reticent to call Emergency 
Medical Services in the event of overdose? International Journal of Drug Policy Vol. 48, 115–
124.  
Lagu, T., Anderson, B.J., & Stein, M. (2006). Overdoses among friends: Drug users are willing 
to administer naloxone to others. Journal of Substance Abuse Treatment, Vol. 30, 129– 133.  
38 
 
Lankenau, S.E., Wagner, K.D., Silva, K., Kecojevic, A., Iverson, E., McNeely M., et al. (2013). 
Injection drug users trained by overdose prevention programs: Responses to witnessed 
overdoses. J Community Health, Vol. 38(1), 133–141.  
Larkin, M., & Griffiths, M.D. (2002). Experiences of Addiction and Recovery: the Case for 
Subjective Accounts. Addiction Research & Theory, Vol. 10(3), 281-311.  
Lewas, D.A., Park, J.N., Vail, L., Sine, M., Welsh, C., & Sherman, S.G. (2016). Evaluation of the 
Overdose Education and Naloxone Distribution Program of the Baltimore Student Harm 
Reduction Coalition. Am J Public Health, Vol. 106(7), 1243-1246. 
Lloyd, C. (2013). The stigmatization of problem drug users: A narrative literature review. 
Drugs: education, prevention and policy, Vol. 20(2), 85–95. 
Madah-Amir, D., Clausen, T., & Lobmaier, P. (2017). Rapid widespread distribution of 
intranasal naloxone for overdose prevention. Drug Alcohol Depend. Vol. 173, 17-23.  
McAuley, A., Lindsay, G., Woods, M., & Louttit, D. (2010). Responsible management and use 
of personal take-home naloxone supply: A pilot project. Drugs: Education, Prevention and 
Policy, Vol. 4, 388–399.  
McAuley, A., Best, D., Taylor, A., Hunter, C., & Robertson, R. (2012). From evidence to policy: 
the Scottish national naloxone programme. Drugs: Education, Prevention & Policy, Vol. 19, 
309-319. 
39 
 
McAuley, A., Aucott. L., & Matheson, C. (2015). Exploring the life-saving potential of 
naloxone: A systematic review and descriptive meta-analysis of take home naloxone (THN) 
programmes for opioid users. International Journal of Drug Policy, Vol. 26, 1183–1188.  
McAuley, A., Munro, A., Bird, S.M., Hutchinson, S.J., Goldberg, D.J., & Taylor, A. (2016). 
Engagement in a National Naloxone Programme among people who inject drugs. Drug 
Alcohol Depend., Vol. 162, 236-240. 
McDonald, R., & Strang, J. (2016). Are take-home naloxone programmes effective? 
Systematic review utilizing application of the Bradford Hill criteria. Addiction, Vol. 111(7), 
1177-1187. 
McLean, K. (2016). “There's nothing here”: Deindustrialization as risk environment for 
overdose. International Journal of Drug Policy, Vol. 29, 19-26. 
Mueller, S.R., Walley, A.Y., Calcaterra, S.L., Glanz, J.M., & Binswanger, I.A. (2015). A review 
of opioid overdose prevention and naloxone prescribing: Implications for translating 
community programming into clinical practice. Substance Abuse, Vol. 36(2), 240–253. 
National Records of Scotland. Drug-Related Deaths in Scotland in 2016. Retrieved 25 August, 
2017 from: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-
theme/vital-events/deaths/drug-related-deaths-in-scotland/2016     
National Treatment Agency for Substance Misuse. The NTA Overdose and Naloxone Training 
Programme for Families and Carers. Retrieved 27 October, 2015 from: 
http://www.nta.nhs.uk/uploads/naloxonereport2011.pdf  
40 
 
Neale, J., & Strang, J. (2015). Naloxone—does over-antagonism matter? Evidence of 
iatrogenic harm after emergency treatment of heroin/opioid overdose. Addiction, Vol. 110, 
1644–1652.  
Office for National Statistics. Deaths related to drug poisoning in England and Wales: 2016 
registrations. Retrieved 27 October 2017, from: 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/death
s/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2016registrations  
Overstall, A., King, R., Bird, S.M., Hay, G., & Hutchinson, S.J. (2014). Incomplete contingency 
tables with censored cells with application to estimating the number of people who inject 
drugs in Scotland. Stat. Med., Vol. 33, 1564–1579. 
Ray, B., O'Donnell, D., & Kahre K. (2015). Police officer attitudes towards intranasal 
naloxone training. Drug Alcohol Depend., Vol. 146, 107-110.  
Reid, K., Flowers, P. & Larkin, M. (2005). Exploring lived experience: An introduction to 
Interpretative Phenomenological Analysis. The Psychologist, Vol. 18, 20-23. 
Rhodes, T. (2009). Risk environments and drug harms: a social science for harm reduction 
approach. Int J Drug Policy, Vol. 20(3), 193-201. 
Rogers, E M. (1983). Diffusion of Innovations (3rd Edn). New York: The Free Press. 
Rome, A., Shaw, A., & Boyle, K. (2008). Reducing Drug Users’ Risk of Overdose. Edinburgh: 
Scottish Government.  
41 
 
Rudd, R.A., Seth, P., David, F., & Scholl, L. Increases in Drug and Opioid-Involved Overdose 
Deaths — United States, 2010–2015. MMWR Morb Mortal Wkly Rep. ePub: 16 December 
2016.  
Shaw, S., Cartwright, A., Spratley, T., & Harwin, J. (1978). Responding to Drinking Problems. 
London: Croom Helm. 
Shaw, R.L. (2010). Embedding reflexivity within experiential qualitative psychology. 
Qualitative Research in Psychology, Vol. 7(3), 233-243. 
Sherman, S.G., Gann, D.S., Tobin, K.E., Latkin, C.A., Welsh, W., & Bielenson, P. (2009). “The 
life they save may be mine”: Diffusion of overdose prevention information from a city 
sponsored programme. International Journal of Drug Policy, Vol. 20(2), 137-142. 
Sherman, S., Gann, D.S., Scott, G., Carlberg, S., Bigg, D., & Heimer, R. (2008). A qualitative 
study of overdose responses among Chicago IDUs. Harm Reduct J., Vol. 5,2.  
Shorter, G.W., & Bingham, T. (2016). Service Review: Take Home Naloxone programme in 
NI. Consultation with service users and service providers. Belfast: Public Health Agency. 
Smith, J.A. (1996). Beyond the divide between cognition and discourse: Using interpretative 
phenomenological analysis in health psychology. Psychology & Health, Vol. 11, 261-271. 
Smith, J.A. (2004). Reflecting on the development of interpretative phenomenological 
analysis and its contribution to qualitative research in psychology. Qualitative Research in 
Psychology, Vol. 1, 39–54. 
42 
 
Smith, J.A., & Osborn, M. (2008). Interpretative phenomenological analysis. In J.A. Smith 
(Ed.) Qualitative Psychology: A Practical Guide to Methods (2nd ed) (pp. 53-81). London: 
Sage.  
Smith, J.A., Flowers, P., & Larkin, M. (2009). Interpretative Phenomenological Analysis: 
Theory, Method, Research. London: Sage. 
Smith, J.A. (2011). Evaluating the contribution of interpretative phenomenological analysis. 
Health Psychology Review, Vol. 5(1), 9-27. 
Sondhi, A., Ryan, G., & Day E. (2016). Stakeholder perceptions and operational barriers in 
the training and distribution of take-home naloxone within prisons in England. Harm 
Reduction Journal, Vol. 13, 5.  
Sporer, K., & Kral, A. (2007). Prescription Naloxone: A Novel Approach to Heroin Overdose 
Prevention. Ann Emerg Med., Vol. 49, 172-177. 
Strang, J., Darke, S., Hall, W., Farrell, M., & Ali, R. (1996). Heroin overdose: The case for take-
home naloxone. British Medical Journal, Vol. 312, 1435–1436. 
Strang, J., Powas, B., Best, D., Vingoe, L., Griffiths, P., Taylor, C., et al. (1999). Preventing 
opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact 
and acceptability. Addiction, Vol. 94, 199–204.  
Strang, J., Bird, S. M., Dietze, P., Gerra, G., & McLellan, A. T. (2014). Take-home emergency 
naloxone to prevent deaths from heroin overdose. Time to save lives. BMJ, Vol. 349, g6580.  
43 
 
Strang, J., Kelleher, M., Best, D., Mayet, S., & Manning, V. (2006). Emergency naloxone for 
heroin overdose – Should it be available over the counter? BMJ, Vol. 333, 614–615. 
Strang, J., Manning, V., Mayet, S., Best, D., Titherington, E., Santana, L., et al. (2008). 
Overdose training and take-home naloxone for opiate users: Prospective cohort study of 
impact on knowledge and attitudes and subsequent management of overdoses. Addiction, 
Vol. 103, 1648–1657. 
Wagner, K.D., Davidson, P.J., Iverson, E., Washburn, R., Burke, E., Kral, A.H., et al. (2014). 'I 
felt like a superhero': The experience of responding to drug overdose among individuals 
trained in overdose prevention. International Journal of Drug Policy, Vol. 25(1), 157-165. 
Wagstaff, J.J., Nolan, M., Wilson, T., Tweedlie, J., Phillips, E., Senu, H., et al. (2014). The 
Accordion and the Deep Bowl of Spaghetti: Eight Researchers’ Experiences of Using IPA as a 
Methodology. The Qualitative Report, Vol. 19(47), 1-15.  
Williams, A., Marsden, J., & Strang, J. (2014). Training family members to manage heroin 
overdose and administer naloxone: randomised trial of effects on knowledge and attitudes. 
Addiction, Vol. 109, 250–259. 
Winston, I., McDonald, R., Tas, B., & Strang J. (2015). Heroin overdose resuscitation with 
naloxone: patient uses own prescribed supply to save the life of a peer. BMJ Case Rep, doi: 
10.1136/bcr-2015-210391 
Worthington, N., Piper, T.M., Galea, S., & Rosenthal, D. (2006). Opiate users' knowledge 
about overdose prevention and naloxone in New York City: a focus group study. Harm 
Reduction Journal, Vol. 3, 19.  
44 
 
Wright, N., Oldham, N., Francis, K., & Jones, L. (2006). Homeless drug users' awareness and 
risk perception of peer "Take Home Naloxone" use – a qualitative study. Subst Abuse Treat 
Prev Policy, Vol. 1, 28.  
 
